搜索结果

Search Results for " lfa-1 "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T21781	A-286982	Integrin	Cytoskeletal Signaling
	A 286982是高效的LFA-1/ICAM-1相互作用变构抑制剂，在LFA-1/ICAM-1结合和LFA-1介导的细胞粘附实验中，其IC50分别为44和35 nM。
T3977	Lifitegrast SHP-606,SAR 1118,立他司特,利非司特	Integrin	Cytoskeletal Signaling
	Lifitegrast (SAR 1118) 是一种整合素淋巴细胞功能相关抗原 1 拮抗剂，抑制 Jurkat T 细胞附着于ICAM-1的IC50为 2.98 nM。
T14676	BMS-688521	Integrin	Cytoskeletal Signaling
	BMS-688521 是一种具有口服活性和高效性的 LFA-1/ICAM 相互作用抑制剂，是白细胞功能相关抗原-1 （LFA-1）的小分子拮抗剂，具有潜在的抗炎活性。
T12783	RWJ 50271	Integrin	Cytoskeletal Signaling
	RWJ 50271 是具有口服活性的选择性LFA-1/ICAM-1相互作用抑制剂，抑制 LFA-1/ICAM-1 介导的细胞粘附，在细胞HL60中的IC50值为 5.0 μM。
T23796	BIRT-377 BIRT377,BIRT 377	IL Receptor; Integrin	Cytoskeletal Signaling; Immunology/Inflammation
	BIRT-377 是 ICAM-1 和 LFA-1 的负变构和口服生物利用度抑制剂（Ki = 25.8 nM）。 BIRT-377 抑制 IL-2 的产生，可用于有关炎症和免疫疾病的研究。
T76924	Efalizumab Hu1124,HU 1124	Integrin	Cytoskeletal Signaling
	Efalizumab 是一种新型针对 T 细胞的有效调节剂，是人源化 LFA-1 α 亚基（CD11a）单克隆抗体。Efalizumab 对 T 细胞激活、皮肤T细胞运输和T细胞粘附到角质形成细胞有抑制作用，可用于研究斑块银屑病和银屑病关节炎。
T24155	ICAM-1988 ICAM 1988
	ICAM-1988 is a LFA-1 antagonist.
T14558	BI-1950	Integrin	Cytoskeletal Signaling
	BI-1950 is a highly potent lymphocyte function associated antigen-1 (LFA-1) inhibitor and the LFA-1 is an essential component in normal immune system function and a target for drug discovery[1].
T30533	BMS-587101 UNII-5V7E4UQL93
	BMS-587101 is a small molecule antagonist of LFA-1, which can reduce inflammation and joint destruction in the mouse model of arthritis.
T40274	XVA143 XVA143
	XVA143, an α/β I-like allosteric antagonist, inhibits LFA-1 dependent firm adhesion, while at the same time it enhances adhesion in shear flow and rolling both in vitro and in vivo. XVA143 is an antagonist of both mouse and human CR3, inhibits the ability of P. gingivalis to persist in the mouse host and cause periodontal bone loss.
T3977L	Lifitegrast sodium SAR-1118-023,SAR1118-023,SAR 1118-023,Xiidra
	Lifitegrast sodium (SAR-1118) is an LFA-1 antagonist for the therapy of vascular complications of the eye. It inhibits T cell-mediated inflammation by blocking the binding of two cell surface proteins (lymphocyte function-associated antigen 1 and intercel
T77106	Odulimomab
	Odulimomab (anti-LFA1) 是一种抗 LFA-1单克隆抗体。Odulimomab 抑制 T 淋巴细胞增殖，对缺血再灌注损伤有保护作用。Odulimomab 可用于移植排斥反应和免疫疾病的研究。